Avellino Laboratories

Avellino Laboratories is a private, precision health company founded in 2007 and headquartered in Menlo Park, California. It operates at the intersection of genomics, diagnostics, and AI/ML, with a pipeline targeting genetic diagnostics for glaucoma, macular degeneration, oncology, and pathogenomics. The company appears to be in a commercial stage for its diagnostic services (e.g., COVID & RSV testing) while developing its therapeutic pipeline, positioning it as a data-driven player in the growing field of predictive and personalized medicine.

AI- and machine learning-powered genetic discovery engine for analyzing genomic and health data to develop diagnostics, polygenic risk scores, and therapeutic targets, including for gene editing.

Avellino competes with large genomic testing companies (e.g., Invitae, Quest, Labcorp), specialized ophthalmology genetic firms, and a growing number of AI-driven drug discovery startups. Its differentiation lies in its integrated focus on ophthalmology genetics, pathogenomics, and its stated path towards gene editing therapies.